UroGen Pharma Ltd.
DE ˙ DB ˙ IL0011407140
23,18 € ↑0,82 (3,67%)
2026-06-05
AKTIENPREIS
SecurityDE:UR8 / UroGen Pharma Ltd.
InstitutionBarclays Plc
Latest Disclosed Ownership57,744 shares
Latest Disclosed Value $ 1,352,364
Barclays Plc reports 3.82% increase in ownership of UR8 / UroGen Pharma Ltd.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 57,744 shares of UroGen Pharma Ltd. (DE:UR8) valued at $1,114,459 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 55,619 shares of UroGen Pharma Ltd.. This represents a change in shares of 3.82% during the quarter. The current value of the position is $1,338,506 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F UROGEN PHARMA COM M96088105 57,744 2,125 3.82 1,352 21.91 0.0003
2026-03-31 2025-09-30 13F/A-3 UROGEN PHARMA COM M96088105 55,619 -14,535 -20.72 1,110 15.40 0.0002
2026-03-19 2025-09-30 13F/A-2 UROGEN PHARMA COM M96088105 59,778 -10,376 759 0.0002
2025-11-12 2025-09-30 13F UROGEN PHARMA COM M96088105 55,619 -14,535 1,110 0.0002
2026-02-27 2025-06-30 13F/A-2 UROGEN PHARMA COM M96088105 70,154 25,614 57.51 961 95.33 0.0002
2025-08-14 2025-06-30 13F/A-1 UROGEN PHARMA COM M96088105 70,154 25,614 1 0.0002
2025-08-13 2025-06-30 13F UROGEN PHARMA COM M96088105 70,154 25,614 1 0.0001
2026-03-17 2025-03-31 13F/A-1 UROGEN PHARMA COM M96088105 44,540 -24,785 -35.75 493 -33.33 0.0001
2025-05-15 2025-03-31 13F UROGEN PHARMA COM M96088105 44,540 -24,785 0 0.0001
2026-03-19 2024-12-31 13F/A-1 UROGEN PHARMA COM M96088105 69,325 9,547 15.97 738 -2.77 0.0002
2025-02-13 2024-12-31 13F UROGEN PHARMA COM M96088105 69,325 9,547 1 0.0002
2026-03-31 2024-09-30 13F/A-2 UROGEN PHARMA COM M96088105 59,778 48,040 409.27 759 287.24 0.0002
2024-11-19 2024-09-30 13F/A-1 UROGEN PHARMA COM M96088105 59,778 48,040 1 0.0002
2024-11-15 2024-09-30 13F UROGEN PHARMA COM M96088105 59,778 48,040 1 0.0001
2026-03-23 2024-06-30 13F/A-1 UROGEN PHARMA COM M96088105 11,738 -7,674 -39.53 197 -32.65 0.0001
2024-08-14 2024-06-30 13F UROGEN PHARMA COM M96088105 11,738 -7,674 0 0.0001
2026-03-24 2024-03-31 13F/A-1 UROGEN PHARMA COM M96088105 19,412 -17,955 -48.05 291 -48.04 0.0001
2024-05-15 2024-03-31 13F UROGEN PHARMA COM M96088105 19,412 -17,955 0 0.0001
2026-03-25 2023-12-31 13F/A-1 UROGEN PHARMA COM M96088105 37,367 33,946 992.28 561 1,091.49 0.0002
2024-02-15 2023-12-31 13F UROGEN PHARMA COM M96088105 37,367 33,946 1 0.0002
2026-03-26 2023-09-30 13F/A-1 UROGEN PHARMA COM M96088105 3,421 -480 -12.30 48 17.50 0.0000
2023-11-07 2023-09-30 13F UROGEN PHARMA COM M96088105 3,421 -480 0 0.0000
2026-03-30 2023-06-30 13F/A-2 UROGEN PHARMA COM M96088105 3,901 -4,247 -52.12 40 -46.67 0.0000
2023-09-20 2023-06-30 13F/A-1 UROGEN PHARMA COM M96088105 3,901 -4,247 0 0.0000
2023-08-03 2023-06-30 13F UROGEN PHARMA COM M96088105 3,901 -4,247 0 0.0000
2026-03-30 2023-03-31 13F/A-1 UROGEN PHARMA COM M96088105 8,148 -6,451 -44.19 75 -41.86 0.0000
2023-05-04 2023-03-31 13F UROGEN PHARMA COM M96088105 8,148 -6,451 0 0.0000
2026-03-30 2022-12-31 13F/A-1 UROGEN PHARMA COM M96088105 14,599 10,817 286.01 129 316.13 0.0001
2023-02-13 2022-12-31 13F UROGEN PHARMA COM M96088105 14,599 10,817 0 0.0001
2022-11-03 2022-09-30 13F UROGEN PHARMA COM M96088105 3,782 0 0.00 31 0.00 0.0000
2022-08-12 2022-06-30 13F UROGEN PHARMA COM M96088105 3,782 -3,169 -45.59 31 -49.18 0.0000
2022-05-16 2022-03-31 13F UROGEN PHARMA COM M96088105 6,951 -20,508 -74.69 61 -76.63 0.0000
2022-02-23 2021-12-31 13F/A-1 UROGEN PHARMA COM M96088105 27,459 15,699 133.49 261 31.82 0.0001
2022-02-14 2021-12-31 13F UROGEN PHARMA COM M96088105 27,459 15,699 261 0.0000
2021-11-09 2021-09-30 13F UROGEN PHARMA COM M96088105 11,760 5,060 75.52 198 94.12 0.0001
2021-08-13 2021-06-30 13F UROGEN PHARMA COM M96088105 6,700 -13,368 -66.61 102 -73.98 0.0000
2021-05-13 2021-03-31 13F UROGEN PHARMA COM M96088105 20,068 9,490 89.71 392 105.24 0.0002
2021-02-11 2020-12-31 13F UROGEN PHARMA COM M96088105 10,578 -2,480 -18.99 191 -24.21 0.0001
2020-11-12 2020-09-30 13F UROGEN PHARMA COM M96088105 13,058 -2,693 -17.10 252 -38.83 0.0001
2020-08-12 2020-06-30 13F UROGEN PHARMA COM M96088105 15,751 5,367 51.69 412 122.70 0.0003
2020-05-13 2020-03-31 13F UROGEN PHARMA COM M96088105 10,384 -9,369 -47.43 185 -71.97 0.0001
2020-02-10 2019-12-31 13F UROGEN PHARMA COM M96088105 19,753 9,799 98.44 660 178.48 0.0004
2019-11-15 2019-09-30 13F/A-1 UROGEN PHARMA COM M96088105 9,954 -2,172 -17.91 237 -45.64 0.0001
2019-11-14 2019-09-30 13F UROGEN PHARMA COM M96088105 9,954 -2,172 237 54.7947
2019-08-14 2019-06-30 13F UROGEN PHARMA COM M96088105 12,126 -18,437 -60.32 436 -61.38 0.0003
2019-05-15 2019-03-31 13F UROGEN PHARMA COM M96088105 30,563 9,282 43.62 1,129 23.25 0.0008
2019-02-14 2018-12-31 13F UROGEN PHARMA COM M96088105 21,281 1,281 6.41 916 -3.07 0.0007
2018-11-14 2018-09-30 13F UROGEN PHARMA COM M96088105 20,000 -2,600 -11.50 945 -15.93 0.0007
2018-08-14 2018-06-30 13F UROGEN PHARMA COM M96088105 22,600 -2,400 -9.60 1,124 -9.50 0.0010
2018-05-15 2018-03-31 13F UROGEN PHARMA COM M96088105 25,000 25,000 1,242 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.